Science & Justice
Volume 46, Issue 3 , Pages 135-152 , July 2006

Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in the Netherlands

Received 23 December 2004 ,Accepted 10 March 2006.

References 

  1. United Nations Office on Drugs and Crime. World Drug Report 2004.
  2. Cheng WC, Poon NL, Chan MF. Chemical profiling of 3,4-methylene-dioxymethamphetamine (MDMA) tablets seized in Hong Kong. Journal of Forensic Sciences. 2003;48(6):1–11
  3. Gimeno P, Besacier F, Chaudron-Thozet H, Girard J, Lamotte AA. Contribution to the chemical profiling of 3, 4-methylenedioxymethamphetamine (MDMA) tablets. Forensic Science International. 2002;127:1–44
  4. Gimeno P, Besacier F, Chaudron-Thozet H. Optimization of extraction parameters for the chemical profiling of 3, 4-methylenedioxymethamphetamine (MDMA) tablets. Forensic Science International. 2003;132:182–194
  5. Palhol F, Boyer S, Naulet N, Chabrillat M. Impurity profiling of seized MDMA tablets by capillary gas chromatography. Analytical and Bioanalytical Chemistry. 2002;374:274–281
  6. Rashed AM, Anderson RA, King LA. Solid-phase extraction for profiling of ecstasy tablets. Journal of Forensic Sciences. 2000;45(2):413–417
  7. Renton RJ, Cowie JS, Oon MCH. A study of the precursors, intermediates and reaction by-products in the synthesis of 3, 4-methylenedioxymethylamphetamine and its application to forensic drug analysis. Forensic Science International. 1993;60:189–202
  8. Verweij AMA. Impurities in illicit drug preparations: 3, 4-(methylenedioxy)-amphetamine and 3, 4-(methylenedioxy)methylamphetamine. Forensic Science Review. 1992;4(2):138–146
  9. Verweij AMA. Clandestine manufacture of 3, 4-methylenedioxymethylamphetamine (MDMA) by low pressure reductive amination. A mass spectrometric study of some reaction mixtures. Forensic Science International. 1990;45:91–96
  10. Bohn M, Bohn G, Blaschke G. Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3, 4-methylenedioxymethamphetamine. International Journal of Legal Medicine. 1993;106:19–23
  11. Lukaszewski T. Spectroscopic and chromatographic identification of precursors, intermediates, and impurities of 3,4-methylenedioxyamphetamine synthesis. Journal of the Association of Official Analytical Chemists. 1978;61(4):951–967
  12. Comment S, Lock E, Zingg C, Jakob A. The analysis of ecstasy tablets by ICP-MS and ICP-AES. Problems of Forensic Sciences. 2001;46:131–146
  13. Palhol F, Lamoureux C, Chabrillat M, Naulet N. 15N / 14N isotopic ratio and statistical analysis : an efficient way of linking seized Ecstasy tablets. Analytica Chimica Acta. 2004;510:1–8
  14. Springer D, Fritschi G, Maurer HH. Metabolism and toxicological detection of the new designer drug 3’-4’-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry. Journal of Chromatography B. 2003;793:377–388
  15. Swist M, Wilamoski J, Zuba D, Kochana J, Parczewski . A Determination of synthesis route of 1 -(3, 4-methylenedioxyphenyl)-2-propanone (MDP-2-P) based on impurity profiles of MDMA. Forensic Science International. 2005;149:181–192
  16. Clark CR, DeRuiter J, Noggle FT. Analysis of 1-(3-methoxy-4,5-methylenedioxyphenyl)-2-propanamine (MMDA) derivatives synthesized from nutmeg oil and 3-methoxy-4,5-methylenedioxybenzaldehyde. Journal of Chromatographic Science. 1996;34(1):34–42
  17. Geigy Scientific Tables. 8th edition. Ciba-Geigy: Lentner, 1985; 3: 58–60.
  18. Aalberg L, Andersson K, Bertler C, Cole MD, Finnon Y, Huizer H, et al. Development of a harmonised method for the profiling of amphetamines II. Stability of impurities in organic solvents. Forensic Science International. 2005;149:231–241

PII: S1355-0306(06)71588-X

doi: 10.1016/S1355-0306(06)71588-X

Science & Justice
Volume 46, Issue 3 , Pages 135-152 , July 2006

Article Tools